Almost every drug bust announcement mentions a “controlled substance,” and many mention a schedule: Schedule I heroin, Schedule II fentanyl, Schedule IV Xanax. Those labels come from the federal Controlled Substances Act, and they shape how drugs are regulated, prescribed, and prosecuted. Here is what each schedule means and why some placements surprise people.
Where the schedules come from
Congress passed the Controlled Substances Act (CSA) in 1970. It sorts regulated drugs into five schedules based on three main questions, found in 21 U.S.C. § 812:
- How high is the potential for abuse?
- Does the drug have a currently accepted medical use in the United States?
- How likely is it to cause physical or psychological dependence?
The Drug Enforcement Administration (DEA) handles scheduling decisions, with a scientific and medical evaluation from the Department of Health and Human Services. Congress can also schedule drugs directly by passing a law.
Schedule I: no accepted medical use
Schedule I drugs have a high potential for abuse and, in the federal government’s view, no currently accepted medical use in treatment in the U.S. They cannot be prescribed.
Examples: heroin, LSD, MDMA (ecstasy), psilocybin, peyote, and most marijuana.
The “no medical use” test is why Schedule I does not mean “most dangerous.” Fentanyl kills far more Americans than LSD, yet fentanyl sits in Schedule II because it is a legitimate hospital painkiller.
Schedule II: medical use, high abuse potential
Schedule II drugs have accepted medical uses but a high potential for abuse that can lead to severe dependence. Prescriptions are tightly controlled and generally cannot be refilled.
Examples: fentanyl, cocaine (used in some medical procedures), methamphetamine (in a prescription form), oxycodone, hydrocodone, morphine, and stimulants like Adderall.
Most of the drugs in today’s biggest busts, especially fentanyl, cocaine, and meth, are Schedule II.
Schedule III: moderate dependence risk
Schedule III drugs have less abuse potential than I or II and a moderate or low risk of physical dependence.
Examples: ketamine, anabolic steroids and testosterone, and products with limited amounts of codeine such as Tylenol with codeine.
Schedule IV: lower abuse potential
Examples: alprazolam (Xanax), diazepam (Valium), zolpidem (Ambien), and tramadol. Counterfeit “Xanax” bars pressed with other drugs show up regularly in busts, which is one reason the real schedule of a drug can differ from what was actually seized. Lab testing settles what a pill really contains.
Schedule V: lowest abuse potential
Examples: cough preparations with small amounts of codeine and pregabalin (Lyrica).
The 2026 marijuana change
Marijuana has been Schedule I since the CSA took effect, even as most states legalized it for medical or recreational use. That started to change in 2026. In a final order announced in April 2026, the Justice Department and DEA moved two categories of marijuana to Schedule III:
- marijuana in FDA-approved drug products, and
- marijuana covered by a state medical marijuana license.
Everything else, including unlicensed grows, bulk marijuana sold outside a licensed program, and recreational marijuana, stayed in Schedule I. DEA held a separate hearing in summer 2026 on moving all marijuana to Schedule III, and a final decision on that broader change was still pending as of fall 2026. We will update this guide when it is decided.
The practical takeaway for drug-bust readers: an illegal grow operation or a trafficking load of marijuana is still a federal crime, and rescheduling did not legalize recreational use under federal law. Federal penalties are still driven by weight (see federal trafficking penalties by drug and weight).
Does the schedule decide the sentence?
Partly. Federal penalties depend on both the schedule and the specific drug and quantity. Schedule I and II drugs carry the heaviest penalties, and the biggest mandatory minimums are written for specific drugs like fentanyl, heroin, cocaine, and meth. Lower schedules carry lower maximums. States run their own schedules too, and they usually track the federal list but do not always match it.
Analogues and new drugs
Chemists keep inventing new drugs that are slightly different from scheduled ones. The Federal Analogue Act treats substances “substantially similar” to Schedule I or II drugs as Schedule I if intended for human consumption. DEA can also temporarily schedule an emerging drug on an emergency basis. That process has been used repeatedly for fentanyl-related substances and synthetic cannabinoids. Some new threats, like the animal sedative xylazine, raise the question of how to control a drug that also has a legitimate veterinary use.
Quick reference
| Schedule | Medical use? | Abuse potential | Examples |
|---|---|---|---|
| I | No (federally) | High | Heroin, LSD, MDMA, unlicensed marijuana |
| II | Yes | High | Fentanyl, cocaine, meth, oxycodone |
| III | Yes | Moderate | Ketamine, steroids, licensed medical marijuana |
| IV | Yes | Lower | Xanax, Valium, Ambien, tramadol |
| V | Yes | Lowest | Low-dose codeine cough syrups, Lyrica |
This guide explains how the law generally works. It is not legal advice. Anyone facing charges should talk to a criminal defense attorney licensed in their state.